Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTISEPSIS aspirin substudy for sepsis outcomes in ASPREE
ACTRN12613000349741Phase 4Completed
- Sponsor
- National Health and Medical Research Council
- Start
- Jan 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in sepsis comparing Aspirin with Placebo (2 arms). Primary endpoint: mortality due to sepsis. Started Jan 2011; status: completed.
02
Drugs
aspirin
03
Conditions
sepsis
Beyond the preview
Go deeper on ACTRN12613000349741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613000349741.